Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
26.64
-1.53 (-5.43%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $4.25 billion as of October 30, 2026. It is the 3,985th most valuable company in the world and the 1,270th biggest in the United States. Its market cap has increased by 66.20% in one year.
Market Cap
4.25B
Enterprise Value
4.29B
1-Year Change
66.20%
Global Rank
Country Rank
#1,270 United States
Category
ChartMarket Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $4.25B, a decrease of -10.95%. That is a compound annual growth rate of -1.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 4.25B | 71.49% |
| Dec 31, 2025 | 2.48B | 180.23% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Qiagen | 10.36B |
| GRAIL | 7.12B |
| RadNet | 5.84B |
| BillionToOne | 5.38B |
| Sotera Health Company | 5.35B |
| Veracyte | 4.07B |
| CareDx | 3.72B |
| NeoGenomics | 2.25B |